Arrhythmia Monitoring: The Challenges Of Detecting AF In Cryptogenic Stroke

Innovation in arrhythmia monitoring technologies, as well as new research showing how these devices may improve arrhythmia diagnosis and management, particularly in cryptogenic stroke patients, will help drive growth in the market for outpatient ambulatory cardiac monitoring devices, which is valued at approximately $1.5 billion in the US alone.

More from Clinical Trials

More from R&D